KeyBanc Starts Amphenol (APH) at Buy; Best-in-Class Connector Supplier
Tweet
Share
E-mailGet Alerts APH Hot Sheet
Price: $159.57 --0%
Rating Summary:
16 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 13
Rating Summary:
16 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 13
Join SI Premium – FREE
KeyBanc initiates coverage on Amphenol (NYSE: APH) with a Buy. PT $55.00.
KeyBanc analyst says, "Overall, we believe APH is among our highest quality component manufacturers as we think the Company's unique operating structure and culture yields an extremely nimble and entrepreneurial enterprise with a proven track record of profit resilience even in the most challenging demand environments."
"Our FY12 estimate is set at $3.23 vs. our 2011 estimate of $3.03, which includes our 4Q11 estimate (December) of $0.71 vs. $0.74 in 4Q10. The Company's current guidance policy is to provide annual and quarterly EPS and revenue guidance. For 4Q11, total revenue is expected to fall between $920 million-$940 million, with EPS expected to be in the range of $0.69-$0.71."
For an analyst ratings summary and ratings history on Amphenol click here. For more ratings news on Amphenol click here.
Shares of Amphenol closed at $45.33 yesterday.
KeyBanc analyst says, "Overall, we believe APH is among our highest quality component manufacturers as we think the Company's unique operating structure and culture yields an extremely nimble and entrepreneurial enterprise with a proven track record of profit resilience even in the most challenging demand environments."
"Our FY12 estimate is set at $3.23 vs. our 2011 estimate of $3.03, which includes our 4Q11 estimate (December) of $0.71 vs. $0.74 in 4Q10. The Company's current guidance policy is to provide annual and quarterly EPS and revenue guidance. For 4Q11, total revenue is expected to fall between $920 million-$940 million, with EPS expected to be in the range of $0.69-$0.71."
For an analyst ratings summary and ratings history on Amphenol click here. For more ratings news on Amphenol click here.
Shares of Amphenol closed at $45.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
- BMO Capital Starts Prime Medicine (PRME) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
KeyBancSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
